Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension.
暂无分享，去创建一个
P. Furet | I. Konstantinova | A. Saunders | B. Wen | V. Molteni | R. Stringer | J. Reilly | C. Thomson | V. Yeh | A. Pearce | Jon Loren | L. Sviridenko | M. Hussey | Matthew J. Thomas | S. Chamoin | Duncan E Shaw | I. Bruce | F. Baig | Peter Drückes | C. Tomlins | Sonia Roberts | S. Collingwood | Vikki Furminger | D. Haggart | Satish Dayal | Sarah Cross